Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,132.18
+2,820.17(+5.96%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Lyra Therapeutics, Inc. (LYRA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

4.0300

-0.6000

(-12.96%)

At close: 04:00PM EDT

4.2200

+0.19

(+4.71%)

After hours:

07:23PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	275.42M
Enterprise value	199.54M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	147.37
Price/book (mrq)	3.08
Enterprise value/revenue	128.08
Enterprise value/EBITDA	-3.06

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	76.72%
S&P500 52-week change ³	22.43%
52-week high ³	6.7900
52-week low ³	2.3600
50-day moving average ³	5.5235
200-day moving average ³	4.3319

Share statistics

Avg vol (3-month) ³	368.29k
Avg vol (10-day) ³	269.96k
Shares outstanding ⁵	59.74M
Implied shares outstanding ⁶	69.74M
Float ⁸	26.76M
% held by insiders ¹	1.16%
% held by institutions ¹	81.84%
Shares short (15 Apr 2024) ⁴	333.56k
Short ratio (15 Apr 2024) ⁴	0.72
Short % of float (15 Apr 2024) ⁴	0.82%
Short % of shares outstanding (15 Apr 2024) ⁴	0.56%
Shares short (prior month 15 Mar 2024) ⁴	206.27k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	-4,421.81%

Management effectiveness

Return on assets (ttm)	-38.10%
Return on equity (ttm)	-95.93%

Income statement

Revenue (ttm)	1.68M
Revenue per share (ttm)	0.03
Quarterly revenue growth (yoy)	29.80%
Gross profit (ttm)	N/A
EBITDA	-71.61M
Net income avi to common (ttm)	-68.88M
Diluted EPS (ttm)	-1.1700
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	87.12M
Total cash per share (mrq)	1.43
Total debt (mrq)	37.86M
Total debt/equity (mrq)	48.85%
Current ratio (mrq)	4.78
Book value per share (mrq)	1.27

Cash flow statement

Operating cash flow (ttm)	-69.91M
Levered free cash flow (ttm)	-40.24M